Online application is open until 3 July 2022
Meet us in Paris to interact with key opinion leaders and learn first-hand about practice challenges and controversies in oncology
The most comprehensive series on gastrointestinal cancers – join this highly specialised discussion with top experts
From World GI 2022:
TOPAZ-1 exploratory analysis suggests that adding durvalumab to gemcitabine plus cisplatin improves advanced biliary tract cancer outcomes irrespective of the primary tumour site
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.